Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Sep 10:2024.09.10.24313149.
doi: 10.1101/2024.09.10.24313149.

Antibiotic De-escalation Patterns and Outcomes in Critically Ill Patients with Suspected Pneumonia as Informed by Bronchoalveolar Lavage Results

Mengou Zhu  1 , Chiagozie I Pickens  2 , Nikolay S Markov  2 , Anna Pawlowski  3 , Mengjia Kang  2 , Luke V Rasmussen  4 , James M Walter  2 , Nandita R Nadig  2 , Benjamin D Singer  2 , Richard G Wunderink  2 , Catherine A Gao  2 ; NU SCRIPT Study Investigators
Affiliations

Antibiotic De-escalation Patterns and Outcomes in Critically Ill Patients with Suspected Pneumonia as Informed by Bronchoalveolar Lavage Results

Mengou Zhu et al. medRxiv. .

Update in

Abstract

Background: Antibiotic stewardship in critically ill pneumonia patients is crucial yet challenging, partly due to the limited diagnostic yield of noninvasive infectious tests. In this study, we report an antibiotic prescription pattern informed by bronchoalveolar lavage (BAL) results, where clinicians de-escalate antibiotics based on the combination of quantitative cultures and multiplex PCR rapid diagnostic tests.

Methods: We analyzed data from SCRIPT, a single-center prospective cohort study of mechanically ventilated patients who underwent a BAL for suspected pneumonia. We used the novel Narrow Antibiotic Therapy (NAT) score to quantify day-by-day antibiotic prescription pattern for each suspected pneumonia episode etiology (bacterial, viral, mixed bacterial/viral, microbiology-negative, and non-pneumonia control). We also analyzed and compared clinical outcomes for each pneumonia etiology, including unfavorable outcomes (a composite of in-hospital mortality, discharge to hospice, or requiring lung transplantation during hospitalization), duration of ICU stay, and duration of intubation. Clinical outcomes were compared with the Mann-Whitney U test and Fisher's exact test.

Results: We included 686 patients with 927 pneumonia episodes. NAT score analysis indicated that an antibiotic de-escalation pattern was evident in all pneumonia etiologies except resistant bacterial pneumonia. Microbiology-negative pneumonia was treated similarly to susceptible bacterial pneumonia in terms of antibiotic spectrum. Over a quarter of the time in viral pneumonia episodes, antibiotics were completely discontinued. Unfavorable outcomes were comparable across all pneumonia etiologies. Patients with viral and mixed bacterial/viral pneumonia had longer durations of ICU stay and intubation.

Conclusions: BAL quantitative cultures and multiplex PCR rapid diagnostic tests resulted in prompt antibiotic de-escalation in critically ill pneumonia patients. There was no evidence of increased incidence of unfavorable outcomes.

PubMed Disclaimer

Conflict of interest statement

Declarations of interests: BDS holds US patent 10,905,706, “Compositions and methods to accelerate resolution of acute lung inflammation,” and serves on the scientific advisory board of Zoe Biosciences, in which he holds stock options. Other authors declare no conflicts of interest.

Figures

Figure 1.
Figure 1.
(A) Examples of the NAT score scenarios and (B) day by day examples of different clinical scenarios. The example NAT table and scenarios are adapted from our group’s prior work, references [11] and [22].
Figure 2.
Figure 2.
Flow diagram of patients included in the different analyses. All patients with suspected pneumonia episodes were included in the antibiotic de-escalation analysis. Patients who had exactly one suspected pneumonia episode was included in the outcomes analysis.
Figure 3.
Figure 3.
Variable patterns of antibiotic de-escalation, by category of pneumonia. Median NAT score per pneumonia episode day, with error bars representing IQR. If a patient died or was discharged before day 7, the days after death or discharge are not included in the plot. Plots B and C are subcategories of plot A, plots H and I are subcategories of plot G.
Figure 4.
Figure 4.
The average NAT score of days 1–7 relative to BAL collection shows the range of antibiotic de-escalation patterns across different episode etiologies. ‘Bacterial (resistant)’ and ‘bacterial (susceptible)’ are subcategories of ‘bacterial’ episodes.
Figure 5.
Figure 5.
Average NAT score of days 1–7 relative to BAL collection, stratified by cure status on day 7. (*: P<0.05; **: P<0.01; ***: P<0.001; ****: P<0.0001)
Figure 6.
Figure 6.
Average NAT score of days 1–7 relative to BAL collection, stratified by the presence or absence of extra-pulmonary infections. (ns: not statistically significant; *: P<0.05; **: P<0.01; ***: P<0.001; ****: P<0.0001)
See this image and copyright information in PMC

References

    1. World Health Organization. The Top 10 Causes of Death.
    1. Wunderink RG, Srinivasan A, Barie PS, et al. Antibiotic stewardship in the intensive care unit : An official American thoracic society workshop report in collaboration with the aacn, chest, cdc, and sccm. Ann Am Thorac Soc. 2020;17(5):531–540. doi: 10.1513/AnnalsATS.202003-188ST - DOI - PMC - PubMed
    1. Deshpande A, Richter SS, Haessler S, et al. De-escalation of Empiric Antibiotics Following Negative Cultures in Hospitalized Patients With Pneumonia: Rates and Outcomes. Clin Infect Dis. 2021;72(8):1314–1322. doi: 10.1093/cid/ciaa212 - DOI - PMC - PubMed
    1. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):E45–E67. doi: 10.1164/rccm.201908-1581ST - DOI - PMC - PubMed
    1. Kalil AC, Metersky ML, Klompas M, et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016;63(5):e61–e111. doi: 10.1093/cid/ciw353 - DOI - PMC - PubMed

Publication types

LinkOut - more resources